Related by context. All words. (Click for frequent words.) 73 dose dexamethasone 72 dose cytarabine 71 relapsed MM 70 dose atorvastatin 69 grade cervical dysplasia 68 ara C 68 dose cyclophosphamide 68 azacytidine 68 refractory chronic lymphocytic 68 gemcitabine carboplatin 68 ® lenalidomide 68 dose interleukin 68 ZACTIMA 67 metastatic malignant 67 Doxil ® 67 docetaxel Taxotere ® 67 MGd 67 PEG IFN 67 cisplatin gemcitabine 67 grade glioma 67 dose methotrexate 66 stage IIIb IV 66 TPV r 66 galiximab 66 chemoradiation therapy 66 CIMZIA TM 66 recurrent glioblastoma multiforme 66 TTF Therapy 66 intravesical therapy 66 CHAMPION PCI 66 melphalan prednisone 66 alfa 2a 66 concurrent chemoradiation 66 Fludarabine 66 Gliadel Wafer 66 dexamethasone Decadron 66 Fludara ® 66 CLL SLL 66 plus dexamethasone 66 complete cytogenetic response 65 unfractionated heparin UFH 65 CIMZIA ™ 65 BrachySil TM 65 dasatinib Sprycel 65 standard chemotherapy regimen 65 chlorambucil 65 doxorubicin docetaxel 65 epoetin alpha 65 Cyclophosphamide 65 evaluating tivozanib 65 grade cervical intraepithelial 65 previously untreated follicular 65 demonstrated antitumor activity 65 cinacalcet 65 oral rivaroxaban 65 APTIVUS R 65 paclitaxel Taxol R 65 valsartan amlodipine 65 PSMA ADC 65 MabCampath 65 Pemetrexed 65 receptor tyrosine kinase inhibitor 65 Omacetaxine 65 HSCT 65 ritonavir boosted 65 sorafenib Nexavar 65 CHOP chemotherapy 65 unresectable tumors 64 Flu Cy 64 FUSILEV enhances 64 relapsing multiple sclerosis 64 histologically confirmed 64 Renal Cell Carcinoma RCC 64 cisplatin chemotherapy 64 adalimumab Humira 64 erlotinib Tarceva ® 64 Decitabine 64 sorafenib Nexavar ® 64 thalidomide Thalomid 64 myelodysplastic myeloproliferative diseases 64 PSA nadir 64 azilsartan medoxomil 64 ER CHOP 64 bendamustine 64 rFSH 64 chemoradiotherapy 64 Tarceva TM 64 MCyR 64 YONDELIS 64 sunitinib malate 64 CIMZIA TM certolizumab pegol 64 pegylated liposomal doxorubicin 64 CTAP# Capsules 64 bolus dose 64 Hycamtin ® 64 chemotherapy cisplatin 64 carmustine 64 trastuzumab Herceptin ® 64 adefovir dipivoxil 64 biologic DMARD 64 bevacizumab Avastin ® 64 Melphalan 64 fluvastatin 64 fluoropyrimidine 64 SCIg 64 gemcitabine cisplatin 64 mycophenolate mofetil MMF 64 underwent surgical resection 64 Pegylated Interferon 64 PEGINTRON TM 64 HER2 positive metastatic breast 64 dose Iluvien 64 dose cohort 64 octreotide 64 grade gliomas 64 docetaxel chemotherapy 64 daunorubicin 64 Degarelix 64 postoperative chemotherapy 64 Peginterferon alfa 2b 64 radiotherapy RT 64 etanercept Enbrel 64 ATACAND 64 vincristine doxorubicin 64 T1c 64 BCG refractory 64 autologous hematopoietic stem cell 64 papillary renal cell carcinoma 64 generation purine nucleoside 64 Neoadjuvant 64 TMC# r 64 dose clopidogrel 64 certolizumab 64 Azacitidine 63 Folfox 63 busulfan 63 mycophenolate mofetil 63 Allogeneic 63 PEGylated interferon 63 non splenectomized 63 8mg/kg 63 partial remissions 63 docetaxel Taxotere R 63 placebo dexamethasone 63 hyperphenylalaninemia HPA due 63 lenalidomide Revlimid R 63 neoadjuvant treatment 63 Pharmacokinetics PK 63 colorectal liver metastases 63 paclitaxel Taxol 63 basiliximab 63 oblimersen 63 Amrubicin 63 oral allopurinol 63 undetectable HBV DNA 63 oral clodronate 63 vidofludimus 63 allogeneic hematopoietic stem cell 63 Mitoxantrone 63 pegylated interferon alfa 63 fallopian tube cancers 63 dose cohorts 63 lumiliximab 63 autologous stem cell 63 Aptivus ® 63 Bezielle 63 liposomal doxorubicin 63 humanised monoclonal antibody 63 Pegylated Liposomal Doxorubicin 63 metastatic GIST 63 Peginterferon 63 ACTEMRA TM 63 Vidofludimus 63 SIR Spheres 63 cytoreduction 63 BENICAR HCT 63 intravenous cyclophosphamide 63 teriflunomide 63 cytoreductive nephrectomy 63 Vidaza azacitidine 63 nucleotide analog 63 subcutaneous immunoglobulin 63 adjuvant cisplatin 63 comparator arm 63 forodesine 63 etoposide 63 VELCADE melphalan 63 haematologic 63 alpha 2a 63 dimeglumine 63 FOLPI 63 vinca alkaloid 63 somatostatin analog 63 nicardipine 63 trans retinoic acid 63 Neulasta ® 63 Angiotensin Converting Enzyme 63 riociguat 63 deferiprone 63 Copegus ribavirin 63 Pegasys peginterferon alfa 2a 63 Lenalidomide 63 leukemia AML 63 decitabine 63 thetreatment 63 Xelox 63 ErbB2 positive 63 CLARITY study 63 paclitaxel Taxol ® 63 CRp 63 Myocet 63 debulking surgery 63 anthracycline taxane 63 Mycophenolate Mofetil 63 nab paclitaxel 63 colorectal cancer liver metastases 63 DOXIL 63 CYPHER Stent 63 autologous SCT 63 biochemical relapse 63 lenalidomide dexamethasone 63 APTIVUS 63 monoclonal antibody conjugated 63 intravesical 63 induce remission 63 FOLFOX6 63 dosing cohort 63 LEXIVA r 63 CXCR4 expression 63 Natalizumab 63 Navelbine ® 63 relapsed refractory multiple myeloma 63 fosbretabulin 62 adriamycin 62 denileukin diftitox 62 antibody MAb 62 calcineurin inhibitor 62 EGFR TKI 62 cyclophosphamide chemotherapy 62 5 Fluorouracil 62 mg/m2 dose 62 5 fluorouracil leucovorin 62 Nilotinib 62 tipranavir r 62 Ceplene/IL-2 62 ribavirin RBV 62 colorectal adenoma 62 receiving highly emetogenic 62 paricalcitol 62 acute GvHD 62 docetaxel cisplatin 62 CsA 62 CYT# potent vascular disrupting 62 sunitinib Sutent 62 allogeneic stem cell 62 induced macular edema 62 interferon ribavirin 62 external beam radiotherapy 62 paclitaxel poliglumex 62 intratumoral 62 Peg IFN 62 haematopoietic stem cell 62 LymphoStat B belimumab 62 Pegasys plus Copegus 62 reteplase 62 docetaxel Taxotere 62 pain palliation 62 neurologic progression 62 acyclovir Lauriad R 62 Epirubicin 62 inhibitor RG# 62 transarterial 62 mCi kg 62 efavirenz EFV 62 mitomycin 62 eculizumab therapy 62 metastatic renal cell carcinoma 62 Platinol ® 62 pioglitazone HCl 62 BARACLUDE ® 62 recurrent NSCLC 62 Vascugel ® 62 phase IIb clinical 62 MAGE A3 ASCI 62 intradermal injections 62 Parathyroid Hormone 62 Camptosar ® 62 goserelin 62 microgram kg 62 pharmacologically active isomer 62 symptomatic VTE 62 HBeAg + 62 DEB# 62 ascending dose 62 Cardiotoxicity 62 sorafenib tablets 62 Xanafide 62 hepatic metastases 62 myeloablative 62 Temsirolimus 62 FOLFOX4 62 liver histology 62 ABVD 62 Relapsing Remitting Multiple Sclerosis 62 neoadjuvant 62 Fludara 62 mitoxantrone plus 62 stage IIIB 62 recurrent metastatic 62 mapatumumab 62 evaluating REVLIMID 62 assessing T DM1 62 LHRH receptor positive 62 Platinol ® cisplatin 62 intratympanic 62 candesartan cilexetil 62 Belldegrun 62 dacarbazine chemotherapy 62 eluting stent 62 palifermin 62 #F FDG PET 62 smoldering multiple myeloma 62 pegylated alpha interferon 62 VNP#M 62 intradermal injection 62 EBRT 62 iobenguane 62 Alocrest 62 temozolomide TMZ 62 inhaled treprostinil 62 Intra arterial 62 neoadjuvant chemotherapy 62 dose corticosteroids 62 Anthracycline 62 peginterferon alpha 2a 62 estramustine 62 EpCAM expression 62 peg interferon 62 ALN HPN 62 salmeterol fluticasone 62 Ozarelix 62 Cloretazine 62 dose ritonavir 62 doxorubicin cyclophosphamide 62 Pertuzumab 62 metastatic CRC 62 ritonavir boosted lopinavir 62 LEUKINE 62 Femara letrozole 62 Naive Patients 62 Zorbtive TM 62 Transurethral 62 EOquin TM 62 Velcade bortezomib 62 Interferon alfa 62 clinically localized prostate 62 Stage IIB 62 amikacin 62 Interferon beta 1a 62 Bayer HealthCare Onyx Pharmaceuticals 62 GRNVAC1 62 corticosteroid dexamethasone 62 ULORIC 62 dasatinib Sprycel ® 62 visilizumab 62 cyclophosphamide doxorubicin vincristine 62 chemotherapy FOLFOX 62 metastatic hormone refractory 62 Irinotecan 62 brivaracetam 62 ASCT 62 mg m² 62 FluCAM arm 62 randomized multicenter trial 62 NAVISTAR R 62 paclitaxel cisplatin 62 intravesical instillation 62 tumor necrosis 62 mRCC 62 antithymocyte globulin 62 Cetuximab Erbitux 62 porcine derived 62 ® bortezomib 62 cediranib 62 dacarbazine DTIC 61 protease inhibitor PI 61 micafungin 61 Vidaza ® 61 bortezomib Velcade R 61 ISTODAX ® 61 colon carcinoma 61 rituximab Rituxan 61 IFN α 61 lomitapide 61 Patients Treated With 61 completely resected 61 PegIFN 61 Zevalin R Ibritumomab 61 liposomal formulation 61 mucosal healing 61 gemcitabine chemotherapy 61 Bosentan 61 SERCA2a 61 relapsed multiple myeloma 61 triiodothyronine 61 IL# PE#QQR 61 aliskiren amlodipine 61 Gemzar gemcitabine 61 TNF alpha antagonist 61 chemotherapeutic regimen 61 Telintra 61 BRIM2 61 Chemophase 61 glycosylated hemoglobin levels 61 locoregional recurrence 61 sustained virological response 61 carboplatin paclitaxel 61 fluticasone salmeterol 61 idarubicin 61 Engerix B 61 Myelodysplastic Syndrome MDS 61 RAS mutations 61 KRAS mutations occur 61 KNS # 61 BRAF inhibitor 61 5-FU/LV 61 Tumor Response 61 Follicular Lymphoma 61 Phase #b/#a clinical 61 folinic acid 61 refractory AML 61 Retreatment 61 Dacogen decitabine 61 mitomycin C 61 Gamunex C 61 novel histone deacetylase 61 gemcitabine Gemzar ® 61 REYATAZ R 61 atazanavir ritonavir 61 corticosteroid therapy 61 adjuvant radiation 61 mismatched bone marrow 61 FOLFOX6 chemotherapy regimen 61 low dose Iluvien 61 Campath alemtuzumab 61 autologous transplants 61 Adjunctive 61 Cervista HPV HR 61 alefacept 61 vapreotide acetate 61 cis retinoic acid 61 low dose dexamethasone 61 NMIBC 61 chemotherapeutic regimens 61 Adjuvant Treatment 61 infliximab monotherapy 61 HGS# 61 insulin glulisine 61 plus DOXIL 61 grade squamous intraepithelial 61 Simulect 61 posaconazole 61 GW# [003] 61 NSABP B 61 boosted protease inhibitor 61 daily subcutaneous injections 61 locoregional disease 61 beclomethasone dipropionate 61 CANCIDAS 61 atorvastatin #mg 61 SPRYCEL ® 61 doxorubicin HCl liposome injection 61 nadolol 61 omacetaxine mepesuccinate 61 Neupogen ® 61 pegylated interferon alpha 61 multicenter randomized placebo controlled 61 pertuzumab 61 immunomodulatory therapy 61 Mg Usa 61 corifollitropin alfa 61 rALLy clinical trial 61 hA# 61 5 FU leucovorin 61 lenalidomide Revlimid 61 viral kinetics 61 recurrent glioma 61 Nexavar sorafenib 61 BrachySil 61 macrolide antibiotic 61 MabThera Rituxan 61 PEG interferon 61 FIRMAGON 61 Chemoradiation 61 systemic ALCL 61 oral Hycamtin 61 fluorouracil leucovorin 61 R sorafenib tablets 61 relapsed Acute Myeloid 61 pegylated liposomal doxorubicin PLD 61 Etoposide 61 registrational Phase 61 neratinib 61 taxane chemotherapy 61 mcg BID 61 underwent liver transplantation 61 dalteparin 61 Vidaza R 61 PegIFN RBV 61 TO AVOID PREGNANCY WHILE 61 Pegasys ® 61 azacitidine 61 radiofrequency ablation RFA 61 weekly subcutaneous injections 61 treatment naïve genotype 61 Tekamlo 61 interferon beta therapy 61 huN# DM1 61 de novo kidney transplant 61 hepatic tumors 61 TORISEL 61 chemoembolization 61 relapsed CLL 61 radiochemotherapy 61 TAXUS Express Stent 61 Noxafil 61 CALGB # [002] 61 steroid refractory 61 hepatorenal syndrome 61 metastatic gastric 61 fluorouracil 61 Hormone Refractory Prostate Cancer 61 HERCEPTIN 61 stem cell engraftment 61 biliary tract cancer 61 TEMODAL 61 Phase Ib II 61 inhaled iloprost 61 Intravesical 61 MDS MPD 61 plus COPEGUS 61 double blinded randomized 61 Initiate Clinical Trial 61 intraoperative radiotherapy 61 intra arterial 61 pegylated interferon alfa 2a 61 prostate carcinoma 61 FOLFOX chemotherapy 61 investigational protease inhibitor 61 Aliskiren 61 Phase 1a clinical 61 ORENCIA ® 61 Saquinavir 61 aldosterone antagonists 61 zonisamide SR 61 plus prednisone prednisolone 61 Previously Untreated 61 Intravitreal 61 iodixanol 61 conventional DMARDs 61 Sandostatin R 61 Thal Dex 61 TNF antagonist 61 iniparib BSI 61 histologic subtype 61 Prolongs Survival 61 systemic hypotension 61 bevacizumab Avastin R 61 microtubule inhibitor 61 Aflibercept 61 acromegalic patients 61 irinotecan chemotherapy 61 abacavir lamivudine 61 Cleviprex TM clevidipine 61 irbesartan 61 Alkeran 61 remission CR 61 abacavir Ziagen 61 liposomal amphotericin B 61 HDR brachytherapy 61 antithrombotic therapy 60 mcg QD 60 GAMMAGARD 60 histamine dihydrochloride 60 metastatic colorectal carcinoma 60 treatment naive genotype 60 BCR ABL inhibitor 60 ZOLINZA 60 metastatic malignant melanoma 60 tirofiban 60 sustained virologic response 60 gefitinib Iressa 60 anthracyclines taxanes 60 HCV SPRINT 60 Taxotere chemotherapy 60 epithelial tumors 60 Clolar ® 60 HCV RESPOND 2 60 plus prednisone 60 follicular NHL 60 intra arterial chemotherapy 60 severe oral mucositis 60 CINTREDEKIN BESUDOTOX 60 randomized blinded 60 tiuxetan 60 xanthine oxidase inhibitor 60 Elitek 60 ISF# 60 satraplatin Phase 60 HBeAg negative patients 60 Triapine R 60 GOUT 60 PASI scores 60 Dabigatran etexilate 60 telaprevir dosed 60 rt PA 60 farletuzumab 60 CIN2 + 60 interferon alfa 2a 60 pimecrolimus 60 hereditary medullary thyroid 60 Targretin capsules 60 pimecrolimus cream 60 Gleevec resistant 60 lipid lowering agents 60 Moxifloxacin 60 saline placebo 60 pT3 60 Protease Inhibitors 60 intravenous bolus 60 ritonavir boosted atazanavir 60 CCyR 60 letrozole Femara 60 Glioblastoma Multiforme 60 systemic RNAi therapeutic 60 HBeAg seroconversion 60 Revascor TM 60 glycoprotein IIb IIIa inhibitor 60 Instanyl 60 operable breast cancer 60 myocardial necrosis 60 Gleevec Glivec 60 Tipranavir 60 TUMT 60 vinorelbine tartrate 60 5FU 60 Torisel 60 hypercholesterolaemia 60 photocoagulation 60 serum LDL cholesterol 60 Quinamed 60 microbiological eradication 60 corticosteroid dose 60 Inhaled nitric oxide 60 Teriflunomide 60 pediatric acute lymphoblastic 60 epirubicin cyclophosphamide 60 cetuximab Erbitux R 60 Advanced Renal Cell 60 Cloretazine ® 60 interstitial brachytherapy 60 flutamide 60 Relapsed Refractory 60 desvenlafaxine succinate 60 Tarceva erlotinib 60 Eli Lilly Gemzar 60 OvaRex MAb 60 IV Busulfex 60 achieved CCyR 60 Lubiprostone 60 AST ALT 60 mg hydrochlorothiazide 60 Heterozygous Familial Hypercholesterolemia 60 active comparator 60 IFN alfa 60 PPAR gamma agonist 60 cardiac perfusion 60 EURIDIS 60 Accelerated Partial Breast Irradiation 60 oral ridaforolimus 60 lymphocyte count 60 divalproex sodium 60 dose colchicine 60 crizotinib PF # 60 mg kg BID 60 aspirin clopidogrel 60 rFVIIa 60 temsirolimus 60 Darunavir 60 TRISENOX ® 60 RhuDex TM 60 protease inhibitors PIs 60 MYLOTARG 60 Taxotere docetaxel 60 Pioglitazone 60 Vandetanib 60 ALT normalization 60 YERVOY 60 weight heparin LMWH 60 ancrod 60 low dose ritonavir 60 Virulizin ® 60 preoperative chemotherapy 60 invasive candidiasis 60 Patients Receiving 60 binary restenosis 60 Trastuzumab 60 4mg/kg 60 Valopicitabine 60 interferon alfa 2b 60 peripheral sensory neuropathy 60 piperacillin tazobactam 60 oral diclofenac 60 taxane resistant 60 temozolomide Temodar 60 oxycodone CR 60 anastrazole 60 lapatinib Tykerb 60 LHRH agonists 60 thrombocytopenic 60 Mantle Cell Lymphoma 60 neutrophil counts 60 antiretroviral naïve 60 elotuzumab 60 DAPT 60 Ranibizumab 60 ONCASPAR 60 echocardiographic parameters 60 metastatic colorectal 60 transarterial chemoembolization 60 aspartate aminotransferase AST 60 IMiDs ® compound 60 Xeloda ® 60 mCi 60 Panzem R NCD 60 Atypical Hemolytic Uremic Syndrome 60 ChronVac C R 60 imatinib therapy 60 xenograft models 60 Resten MP 60 capecitabine Xeloda 60 Microfocus APA 60 papillary thyroid carcinoma 60 MMX mesalamine 60 liver resection 60 PREZISTA ritonavir 60 nondiabetic patients 60 Castration Resistant Prostate Cancer 60 Panzem NCD 60 maternal serum 60 depsipeptide 60 oxaliplatin Eloxatin 60 antiangiogenic therapy 60 PRT# 60 pharmacodynamic PD 60 hormone refractory metastatic prostate 60 remission induction 60 Posaconazole 60 splenectomized 60 salmeterol fluticasone propionate 60 myelodysplastic syndrome MDS 60 cilengitide 60 hypofractionated 60 intratumoral injection 60 refractory metastatic 60 pegfilgrastim 60 lopinavir r 60 AVONEX ® 60 ThermoDox R 60 cetuximab Erbitux ® 60 BEXXAR Therapeutic Regimen 60 xenograft model 60 ARB telmisartan 60 hypereosinophilic syndrome 60 verteporfin 60 PEGylated interferon beta 1a 60 radiotherapeutic 60 Kamada AAT 60 RezularTM 60 IOP lowering 60 ximelagatran 60 refractory prostate cancer 60 evaluable subjects 60 transplantation HCT 60 iniparib 60 acetonide FA 60 dacarbazine 60 pomalidomide 60 platelet inhibitor 60 VIAject ™ 60 IGF 1R inhibitor 60 Arsenic trioxide 60 Philadelphia Chromosome Positive 60 olmesartan 60 syngeneic 60 lymphoid malignancies 60 HuMax EGFr 60 orally administered inhibitor 60 primary hypercholesterolemia 60 mg kg dose 60 adjuvant tamoxifen 60 Bevacizumab Avastin 60 EFAPROXYN 60 gemcitabine Gemzar 60 temsirolimus Torisel ® 60 Phase Ib clinical 60 ALGRX 60 polycythemia vera essential thrombocythemia 60 Abciximab 60 COPEGUS ribavirin 60 refractory NSCLC 60 allogeneic hematopoietic cell 60 Multiple Myeloma MM 60 Tacrolimus 60 elevated transaminases 60 EGFR HER2 60 Zarnestra 60 total thyroidectomy 60 pancreatic adenocarcinoma 60 pegylated interferon alfa 2b 60 Platinol 60 ImmuKnow 60 investigational monoclonal antibody 60 Antitumor Activity 60 trastuzumab Herceptin R 60 RECORD1 60 liver metastasis 60 adjunctive placebo 60 nonmetastatic 60 lanreotide 60 Metastatic Melanoma 60 Belatacept 60 mm Stent 60 #mg dose [002] 60 oral antidiabetic medication 60 antitumor effect 60 rhBMP 2 60 immunohistochemical staining 60 Radioimmunotherapy 60 lexidronam injection 59 Epratuzumab 59 fludarabine cyclophosphamide 59 lactate dehydrogenase LDH 59 eosinophilic asthma 59 multiple myeloma MM 59 R Saizen R 59 STELARA ™ 59 multicenter randomized controlled 59 heavily pretreated patients 59 PROSTVAC VF 59 resected pancreatic cancer 59 Temodar ® 59 clodronate 59 unresectable liver cancer 59 nonsmall cell lung cancer 59 serum phosphate 59 Danazol 59 Oral Fingolimod 59 relapsed myeloma 59 RECIST Response Evaluation Criteria 59 Phase Ib Clinical Trial 59 peginterferon 59 Elagolix 59 colony stimulating factors 59 Fulvestrant 59 regorafenib 59 virological response 59 gastrointestinal stromal tumors GIST 59 AKT inhibitor 59 allogeneic HSCT 59 Paraplatin ® 59 eplerenone 59 beta 1a 59 Tiuxetan 59 NovoTTF #A 59 BEACOPP 59 argatroban 59 INFERGEN 59 Study Evaluating 59 baseline LDH 59 immunosuppressant drug 59 caspofungin 59 #mg/#mg 59 cutaneous T 59 budesonide pMDI 59 Evoltra ® 59 Mg Uk 59 complete cytogenetic 59 Meets Primary Endpoint 59 GnRH agonist 59 ChronVac C ® 59 lanthanum carbonate 59 locoregional 59 trastuzumab Herceptin 59 gadobutrol 59 concurrent ITP 59 achieved ACR# 59 Seliciclib 59 murine model 59 Chronic Lymphocytic Leukemia CLL 59 prednisone prednisolone 59 FOLFIRI alone 59 Enzyme Replacement Therapy 59 metastatic HRPC 59 grade dysplasia 59 intravesical infusion therapy 59 AGILECT R 59 dornase alfa 59 Vinorelbine 59 thiazide diuretic 59 BENICAR 59 dose regimens 59 blinded randomized placebo controlled 59 pegylated IFN 59 renal cell carcinomas 59 velafermin 59 Zemplar Capsules 59 STRIDE PD 59 CALGB 59 PRADAXA 59 d4T stavudine Zerit 59 glycosylated hemoglobin HbA1c 59 metastatic pancreatic 59 herpetic keratitis 59 adjuvant radiotherapy 59 Enoxaparin 59 TLK# 59 CR CRu 59 chronic hemodialysis 59 effector function 59 surgical resection cavity 59 TYGACIL 59 OHR/AVR# 59 chemoradiation 59 aspartate aminotransferase 59 standard chemotherapy regimens 59 gallium nitrate 59 TRO# 59 IV bolus 59 HBeAg positive patients 59 hematologic toxicity 59 GRN# 59 HBeAg 59 oral prodrug 59 Combination therapy 59 ACE Inhibitor 59 imatinib Gleevec 59 follicular lymphomas 59 thyroglobulin 59 EQUETRO 59 #F FDG 59 GLIADEL R Wafer 59 orally inhaled migraine 59 BR.# 59 rosuvastatin #mg 59 peginterferon alfa 2b 59 non resectable 59 invasive ductal 59 refractory cutaneous T 59 superficial bladder cancer 59 Allovectin 7 ® 59 Kepivance 59 Capecitabine 59 PI3K/Akt pathway inhibitor 59 #mg/m# [002] 59 CRLX# 59 tenofovir emtricitabine 59 trans retinoic acid ATRA 59 maximally tolerated dose 59 AEGR 59 alkylating agent 59 calculated creatinine clearance 59 fallopian tube carcinoma 59 surgical debulking 59 IMiDs ® 59 multikinase inhibitor 59 Traficet EN 59 follicular lymphoma FL 59 blood phenylalanine Phe 59 immunomodulatory agents 59 Ibritumomab Tiuxetan 59 Surgical resection 59 miconazole Lauriad ® 59 pT2 59 rufinamide 59 histone deacetylase inhibitor 59 squamous histology 59 PKC# 59 DAS# CRP 59 ALA PDT 59 oral beclomethasone dipropionate 59 intranasal formulation 59 histological subtype 59 #I TM# 59 HBeAg negative 59 Nebulized 59 OPCAB 59 Ribavirin causes 59 tolterodine ER